INTRODUCTION
============

Reactive oxygen species (ROS) are continuously produced by respiring mitochondria, and their level greatly depends on the mode of electron transport in the respiratory chain. Forward mode of electron transport (forward electron transport \[FET\]) and reverse mode of electron transport can be elicited by substrates of complex I (e.g., glutamate and malate) and complex II (e.g., succinate), respectively ([@bib58]). The former represents the main in vivo physiological pathway of electron flow.

Mitochondria produce ∼85--90% of cellular ROS ([@bib17]; [@bib9]). Sources of ROS other than the respiratory chain include mitochondrial nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX4; [@bib11]; [@bib41]), α-ketoglutarate dehydrogenase ([@bib64]), glycerol 3-phosphate dehydrogenase ([@bib3]; [@bib1]), monoamine oxidase ([@bib37]), and several others ([@bib3]; [@bib43]).

Separate, but interacting, pools of the main redox couples (NADH/NAD^+^, GSH \[reduced glutathione\]/GSSG \[oxidized glutathione\], Trx(SH)~2~ \[reduced Trx\]/TrxSS \[oxidized Trx\], and NADPH/NADP^+^) are present in the cytoplasm, mitochondrial intermembrane space (IMS), and matrix ([@bib5]; [@bib26]; [@bib33]). Redox sensors in cytoplasmic and mitochondrial compartments are capable of dynamic and rapid detection of changes in ROS levels, tuning the antioxidant defenses to respond to intra- or extracellular redox stressors that may perturb mitochondrial and cytosolic redox balance ([@bib5], [@bib7]; [@bib23]; [@bib59]).

The H~2~O~2~ emission flux from mitochondria reflects the balance between the rate of H~2~O~2~ generation, secondary to superoxide production by the respiratory chain and its dismutation to H~2~O~2~, and the rate of H~2~O~2~ scavenging ([@bib3]; [@bib39]; [@bib43]; [@bib65]; [@bib7]). Superoxide dismutation to H~2~O~2~ is accomplished primarily by Mn (mitochondrial matrix), Cu, and Zn (cytoplasmic and mitochondrial IMS) superoxide dismutases (SODs), enzymes with very high rate constants, on the order of 800 µM s^−1^ ([@bib18]). Superoxide can also be oxidized to O~2~ independently of SOD by oxidized cytochrome c (rate constant of ∼1--10 µM s^−1^; [@bib15]) residing in the IMS ([@bib38]; [@bib28]; [@bib46]), although it has been argued that cytochrome c must first be released from the inner membrane before it can serve as an antioxidant ([@bib47]).

The glutathione (GSH) and Trx systems are the two main H~2~O~2~ scavengers that have been characterized in mitochondria from all organs. In the mitochondrial matrix, the Trx system is composed of Trx reductase 2 (TrxR2), Trx2, and peroxiredoxin 3 (Prx3). The GSH system encompasses the activities of glutathione reductase (GR) and glutathione peroxidase (GPx). The cytoplasmic TrxR1 ([@bib35]) and other cytoplasmic antioxidants, such as the GSH system ([@bib33]), Cu, Zn SOD (SOD1), and catalase ([@bib35]), have also been found in the mitochondrial IMS.

The mitochondrial H~2~O~2~ buffering capacity maintains proper reduced/oxidized ratios of GSH and Trx pools as the result of their constitutive enzymatic activities ([@bib39]; [@bib43]; [@bib65]). Trx2/TrxR2 does not directly scavenge H~2~O~2~ but instead supplies electrons to Prx3 ([@bib48]; [@bib20]; [@bib32]). In doing so, Trx2 shifts from a reduced to oxidized form. The activity of both systems, Trx2 and GSH, is dependent on the electron donor NADPH, whose reductive potential in the mitochondrial matrix is set by the activity of the nicotinamide nucleotide transhydrogenase, NADP^+^-dependent isocitrate dehydrogenase, and malic enzyme ([@bib57]; [@bib54]).

The physiological importance of the balance between ROS production and scavenging is underscored by observations in several diseases that ROS can be either protective or damaging ([@bib16]). Diabetes and insulin resistance are associated with decreased antioxidant capacity, reflected as diminished activities of SOD, GPx, and GR ([@bib67]). Under redox-balanced conditions, H~2~O~2~ production is offset by matrix peroxidases, including Prx3 and Prx5 ([@bib52]; [@bib20]), catalase ([@bib51]; [@bib55]), and GPx1 and 4 ([@bib34]). The cytoplasmic and mitochondrial redox environments play an important role in maintaining ROS balance within cardiac myocytes. Cellular and mitochondrial ROS levels are highly responsive to matrix and extramitochondrial scavenging systems. The Redox-optimized ROS Balance hypothesis postulates that oxidative stress can occur at either extreme of the redox potential range, that is, when the intracellular environment is either highly reduced or oxidized ([@bib7]). Previously, we have shown that in permeabilized cardiomyocytes and mitochondria isolated from guinea pig hearts, the rate of ROS accumulation depends on the interplay between extramitochondrial GSH/GSSG ratio and GSH regeneration in the mitochondrial matrix ([@bib5], [@bib7]). At sufficiently oxidized redox environments, the antioxidant defense systems determine the extent of ROS imbalance, which may result in mitochondrial dysfunction and contribute to contractile impairment and whole-heart arrhythmias ([@bib4], [@bib6]; [@bib61]; [@bib14]; [@bib12]).

In the present study, we quantitatively analyzed, by means of experimentation and computational modeling, the relative contribution of the two main antioxidant arms (GSH and Trx1/2) in modulating mitochondrial H~2~O~2~ emission ([Fig. 1](#fig1){ref-type="fig"}). Auranofin (AF) and dinitrochlorobenzene (DNCB) were used to quantitatively characterize the contribution of each system separately and when acting together to scavenge H~2~O~2~. We combined experimental and modeling results to understand in quantitative terms the relative weight of the two major antioxidant systems in preventing H~2~O~2~ emission from mitochondria. Our investigation was performed in isolated heart mitochondria from mouse, rat, and guinea pig, three species that are widely used in cardiovascular science and have different electrophysiological and contractile properties. We also aimed at assessing whether differences related with the aims of this study exist between species that exhibit different maximum life span potential (4, 5, and 12 yr for mouse, rat, and guinea pig, respectively; [@bib10]). This important aspect of our choice was stimulated by the well-established negative correlation found between mitochondrial ROS and maximum life span potential ([@bib56]). Overall, studying mitochondria from several distinct species allowed us to further ascertain the general validity of the results obtained.

![Major pathways of mitochondrial ROS production and ROS scavenging. The scheme depicts the GSH and Trx systems in the mitochondrial matrix as the major H~2~O~2~ scavengers. The NADPH/NADP^+^ couple is the main electron donor of the large-capacity GSH (GSH and GSSG) and the Trx (Trx~red~ and Trx~ox~) systems responsible for scavenging H~2~O~2~ via GPx and Prx enzymes, respectively. GR and TrxR, the two reductases responsible for regenerating the reduced species of both antioxidant defenses, GSH and Trx~red~, are shown. The two inhibitors used in this work and their sites of action are highlighted: AF, the TrxR1/2 inhibitor, and DNCB, an alkylating GSH-depleting agent. The respiratory complexes I, II, III, IV, and V (ATP synthase) in the inner mitochondrial membrane (IMM) are also schematized. O~2~^−^ can be produced by complexes I and III from the electron transport chain through reverse electron transport (RET) or FET (reverse or forward modes of electron transport), which depends on NADH- or flavin adenine dinucleotide hydrogen--linked substrates, such as G/M or succinate (Succ), donating electrons to complex I or II, respectively. O~2~^−^ conversion to H~2~O~2~ by Mn SOD and the tricarboxylic acid (TCA) cycle are depicted as well. In the scheme of the computational model (see [Fig. 4 A](#fig4){ref-type="fig"}), we have split the arrow corresponding to Prx into two processes to account for the cycle of Prx oxidation/reduction as well. These processes are denoted by V~Prx~ and V~txpx~ ([Eqs. 3](#fd3){ref-type="disp-formula"} and [5](#fd5){ref-type="disp-formula"}; see Computational model formulation in Materials and methods).](JGP_201210772_Fig1){#fig1}

MATERIALS AND METHODS
=====================

Mitochondrial isolation
-----------------------

Procedures for the isolation and handling of mitochondria from guinea pig and rat hearts were performed as previously described ([@bib7],[@bib8]). Mitochondria from two pooled mouse hearts were isolated, with slight modifications, as described in [@bib63]. In brief, 0.1mg/ml proteinase (bacterial, type XXIV, formerly called Nagarse; Sigma-Aldrich) was added immediately before the homogenization procedure ([@bib8]). 3 vol of isolation solution (75 mM sucrose, 225 mM mannitol, and 1 mM EGTA, pH 7.4, containing 0.2% fatty acid--free BSA; Sigma-Aldrich) was quickly added after homogenization to block proteinase activity. After a first centrifugation (500 *g* for 10 min) to discard unbroken tissue and debris, the supernatant was centrifuged at 10,000 *g* for 10 min to sediment the mitochondria and washed twice thereafter by centrifugation at 7,700 *g* for 5 min each, the first one with isolation solution in presence of BSA and the second in absence of BSA. In mouse heart mitochondria, respiratory control ratios (state 3/state 4 respirations with 5 mM glutamate + malate or succinate) of five or higher were obtained using this method.

Assay of mitochondrial respiration
----------------------------------

Respiration was assayed in freshly isolated mitochondria with a high-throughput--automated 96-well extracellular flux analyzer (XF96; Seahorse Bioscience) in a medium (buffer B) containing 137 mM KCl, 2 mM KH~2~PO~4~, 0.5 mM EGTA, 2.5 mM MgCl~2~, and 20 mM HEPES at pH 7.2 and 37°C in presence of 0.2% fatty acid--free BSA. Respiration was evaluated with substrates of complex I (glutamate/malate \[G/M\], 5 mM each). The day before the experiment, each of the 96 wells of the XF96 plate was coated with 120 µl polyethylenimine (1:15,000 dilution in buffer B of a 50% solution of polyethylenimine) and incubated overnight in the absence of CO~2~. The next day, the solution of polyethylenimine was removed by vacuum suction. After transferring appropriate amounts of mitochondrial suspension into each well (5--15 µg of mitochondrial protein), the mitochondria were spun down at 3,000 *g* for 7 min at 4°C in a centrifuge with a swinging bucket rotor (S5700; Beckman Coulter) with a microplate adaptor. After centrifugation, the plate was incubated at 37°C for 20 min before starting the assay in the Seahorse Bioscience equipment. Mitochondrial protein was determined using the bicinchoninic acid method protein assay kit (Thermo Fisher Scientific).

Other bioenergetic variables and ROS detection
----------------------------------------------

NAD(P)H and H~2~O~2~ were determined, as previously described ([@bib7],[@bib8]), and monitored simultaneously with a wavelength-scanning fluorometer (QuantaMaster; Photon Technology International, Inc.) using the same aforementioned medium for measuring respiration (excluding BSA) and a multidye program for simultaneous online monitoring of different fluorescent probes. NAD(P)H was monitored by exciting mitochondrial suspensions at 340 nm and collecting the emission at 450 nm. H~2~O~2~ was detected using the Amplex red kit (Invitrogen).

Computational model formulation
-------------------------------

A minimal model of mitochondrial ROS scavenging accounting for the GSH and Trx systems was formulated, taking into account kinetic information available (see scheme in [Fig. 4 A](#fig4){ref-type="fig"}). The rate expressions used in the model were formulated as follows. [Eqs. 1](#fd1){ref-type="disp-formula"} and [2](#fd2){ref-type="disp-formula"} correspond to the same expressions used in our mitochondrial model of ROS metabolism ([@bib19]):$$\mathit{V}_{\mathit{GPx}} = \frac{\text{E}_{\text{GPX}}^{\text{T}}\,\left\lbrack \text{H}_{2}\text{O}_{2} \right\rbrack\,\left\lbrack {GSH} \right\rbrack}{\Phi_{1}\left\lbrack \text{GSH} \right\rbrack + \Phi_{2}\,\left\lbrack \text{H}_{2}\text{O}_{2} \right\rbrack}$$and$$\begin{array}{l}
{V_{GR} =} \\
{\frac{\text{k}_{\text{GR}}^{1}\,\text{E}_{\text{GR}}^{\text{T}}\,\left\lbrack \text{GSSG} \right\rbrack\,\left\lbrack \text{NADPH} \right\rbrack}{{\left\lbrack \text{GSSG} \right\rbrack\,\left\lbrack \text{NADPH} \right\rbrack}\, + \,\text{K}_{\text{M}}^{\text{GSSG}}{\,\left\lbrack \text{NADPH} \right\rbrack} + \text{K}_{\text{M}}^{\text{NADPH}}{\,\left\lbrack \text{GSSG} \right\rbrack} + \text{K}_{\text{M}}^{\text{GSSG}}\,\text{K}_{\text{M}}^{\text{NADPH}}}.} \\
\end{array}$$[Eq. 3](#fd3){ref-type="disp-formula"} was derived on the basis of the experimental studies performed by [@bib68], from which we also obtained the rate constants:$$\mathit{V}_{\mathit{Prx}} = \frac{\text{E}_{\text{PrxX}}^{\text{T}}\,\left\lbrack \text{H}_{2}\text{O}_{2} \right\rbrack\,\left\lbrack \text{Prx}\left( \text{SH}_{2} \right) \right\rbrack^{2}}{\Phi_{\text{P1}}\,\left\lbrack \text{Prx}\left( \text{SH}_{2} \right) \right\rbrack + \Phi_{\text{P2}}\,\left\lbrack \text{H}_{2}\text{O}_{2}\text{]} \right.}.$$[Eq. 4](#fd4){ref-type="disp-formula"} represents a Michaelis--Menten rate expression with two substrates (NADPH and TrxSS), with kinetic parameters derived from [@bib49] and [@bib24]:$$\begin{array}{l}
{V_{TrxR}\text{=}} \\
{\frac{\text{k}_{\text{TrxR}}^{1}\,\text{E}_{\text{TrxR}}^{\text{T}}\,\left\lbrack \text{Trx}\left( \text{SS} \right) \right\rbrack\,\left\lbrack \text{NADPH} \right\rbrack}{{\left\lbrack \text{Trx}\left( \text{SS} \right) \right\rbrack\,\left\lbrack \text{NADPH} \right\rbrack} + \text{K}_{\text{M}}^{\text{TrxSS}}\,\left\lbrack \text{NADPH} \right\rbrack + \text{K}_{\text{M}}^{\text{T-NADPH}}\,\left\lbrack \text{Trx}\left( \text{SS} \right) \right\rbrack + \text{K}_{\text{M}}^{\text{TrxSS}}\,\text{K}_{\text{M}}^{\text{T-NADPH}}}.} \\
\end{array}$$The rate expression of Prx oxidation ([Eq. 5](#fd5){ref-type="disp-formula"}) was based on the model of [@bib49], with adjustable k~txpx~ to simulate the results obtained with heart mitochondria:$$V_{TxPx} = \frac{\text{k}_{\text{TxPx}}^{1}\,\left\lbrack \text{Trx}\left( \text{SH} \right)_{2} \right\rbrack\,\left\lbrack \text{Prx}\left( \text{SS} \right) \right\rbrack}{\left\lbrack \text{Trx}\left( \text{SH} \right)_{2} \right\rbrack + \text{K}_{\text{M}}^{\text{Trx}} + \text{K}_{\text{i}}^{\text{TrxPx}}\,\left\lbrack \text{Trx}\left( \text{SH} \right)_{2} \right\rbrack^{2}}.$$The model contains the following components: (a) TrxR and reduced Prx (Prx(SH)~2~)as part of the Trx system, present in both matrix and IMS, which considers the reduced/oxidized species of Trx and Prx as state variables (both couples linked through conservation relationships); and (b) the GSH system, encompassing the activities of GPx and GR, with GSH/GSSG as state variables, also obeying conservation relations. In the present model, catalase was not taken into account because very low concentrations have been detected in heart mitochondria ([@bib51]) and because we did not observe effects on H~2~O~2~ emission after its inhibition, under the same experimental conditions used in this work ([@bib63]).

In keeping with the main aim of the present work, which was to quantify the role of the GSH/Trx scavenging systems in controlling ROS emission from mitochondria, the following basic questions prompted the use of modeling: (a) are the basic biochemical mechanisms involved in the GSH/Trx scavenging systems sufficient to quantitatively explain the experimentally measured H~2~O~2~ emission fluxes; (b) how do the two scavenging systems behave kinetically when acting together with respect to H~2~O~2~ scavenging; and (c) is another mechanism needed in the model formulation to account for the observed behavior of H~2~O~2~ emission when both systems are inhibited, either independently or in tandem?

In this minimal model, the rate of H~2~O~2~ generation and the concentration of NADPH are adjustable parameters. The input given by the rate of H~2~O~2~ generation represents the activity of SOD (V~SOD~). The rate equations of the individual processes ([Eqs. 1](#fd1){ref-type="disp-formula"}--[5](#fd5){ref-type="disp-formula"}) have been integrated into a system of four ordinary differential equations (see [Table 1](#tbl1){ref-type="table"}). The concentrations of the redox couples GSH/GSSG, Trx(SH)~2~/Trx(SS), and Prx(SH)~2~/Prx(SS) (oxidized Prx) are related through conservation relations ([Eqs. 6](#fd6){ref-type="disp-formula"}--[8](#fd8){ref-type="disp-formula"}):$$G_{T} = \left\lbrack \text{GSH} \right\rbrack + 2\,\left\lbrack \text{GSSG} \right\rbrack,$$$$\mathit{Trx}_{T} = \left\lbrack \text{Trx}\left( \text{SH} \right)_{2} \right\rbrack + \left\lbrack \text{Trx}\left( \text{SS} \right) \right\rbrack,$$and$$\mathit{Prx}_{T} = \left\lbrack \text{Prx}\left( \text{SH} \right)_{2} \right\rbrack + \left\lbrack \text{Prx}\left( \text{SS} \right) \right\rbrack.$$The ordinary differential equation system was numerically integrated with MATCONT ([@bib22]) both for time-dependent behavior and continuation analysis of the steady state as a function of the model parameters. Mathematically, the rate expressions and their parameters were formulated according to reported experimental data (see [Table 2](#tbl2){ref-type="table"}).

###### 

Model differential equations

  State variable   Differential equation
  ---------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  \[H~2~O~2~\]     $\frac{d\left\lbrack H_{2}O_{2} \right\rbrack}{dt} = \text{V}_{\mathit{SOD}}\text{-\ k}_{1} \times \left\lbrack H_{2}O_{2} \right\rbrack\text{-\ V}_{\mathit{Prx}}\text{-\ V}_{\mathit{GPx}}$
  \[GSH\]          $\frac{d\left\lbrack GSH \right\rbrack}{dt}\text{=\ V}_{\mathit{GR}}\text{-\ V}_{\mathit{GPx}}$
  \[Trx(SH)~2~\]   $\frac{d\left\lbrack Trx\left( SH \right)_{2} \right\rbrack}{dt}\text{=\ V}_{\mathit{TrxR}}\text{-\ V}_{\mathit{TxPx}}$
  \[Prx(SH)~2~\]   $\frac{d\left\lbrack \mathit{Prx}\left( SH \right)_{2} \right\rbrack}{dt}\text{=\ V}_{\mathit{TxPx}}\text{-\ V}_{\mathit{Prx}}$

###### 

Parameter values of the computational model

  Symbol                         Value          Unit            Description                                             Equation no.   Reference
  ------------------------------ -------------- --------------- ------------------------------------------------------- -------------- -------------------------------------------
  $E_{\mathit{GPX}}^{T}$         5.0 × 10^−3^   mM              Mitochondrial concentration of GPx                      1              [@bib19]
  Φ~1~                           5.0 × 10^−3^   mM ms           Constant for GPx activity                               1              [@bib19]
  Φ~2~                           0.75           mM ms           Constant for GPx activity                               1              [@bib19]
  $K_{M}^{\mathit{GSSG}}$        0.06           mM              *K*~m~ for oxidized GSH of GR                           2              [@bib19]
  $K_{M}^{\mathit{NADPH}}$       0.015          mM              *K*~m~ for NADPH of GR                                  2              [@bib19]
  $k_{\mathit{GR}}^{1}$          0.025--0.005   ms^−1^          Rate constant of GR                                     2              [@bib19]
  $E_{\mathit{GR}}^{T}$          5.0 × 10^−3^   mM              Mitochondrial concentration of GR                       2              [@bib19]
  *G~T~*                         3.0            mM              Total mitochondrial pool of GSH                         6              [@bib19]
  $E_{\mathit{PrxX}}^{T}$        1              mM              Intracellular concentration of Prx                      3              [@bib20]
  Φ~P1~                          3.83           mM^2^ ms        Constant for Prx 3 activity                             3              [@bib68]
  Φ~P2~                          0.285          mM^2^ ms        Constant for Prx 3 activity                             3              [@bib68]
  $K_{M}^{\mathit{TrxSS}}$       0.05           mM              *K*~m~ for Trx(SS) of TrxR                              4              [@bib49]; [@bib24]
  $K_{M}^{T - \mathit{NADPH}}$   0.012          mM              *K*~m~ for NADPH of TrxR                                4              [@bib49]; [@bib24]
  $k_{\mathit{TrxR}}^{1}$        0.022--0.009   ms^−1^          Rate constant of TrxR                                   4              [@bib49]; [@bib24]
  $E_{\mathit{TrxR}}^{T}$        0.025          mM              Mitochondrial concentration of TrxR                     4              [@bib49]
  $k_{\mathit{TxPx}}^{1}$        2.5            mM^−1^ ms^−1^   Rate constant of Prx                                    5              [@bib20]; [@bib2]
  $K_{M}^{\mathit{Trx}}$         0.1            mM              *K*~m~ for Trx(SH)~2~ of Prx                            5              [@bib2]
  $K_{i}^{\mathit{TrxPx}}$       0.01           mM^−1^          Inhibition constant of Prx activity by Trx(SH)~2~       5              [@bib2]
  Trx~T~                         0.025          mM              Total mitochondrial pool of Trx                         7              [@bib20]
  Prx~T~                         0.15           mM              Total mitochondrial pool of Prx                         8              [@bib20]
  k~1~                           0.1            ms^−1^          Rate constant of H~2~O~2~ transport from mitochondria   9              Adjusted[a](#tblfn1){ref-type="table-fn"}

This parameter (k~1~) was adjusted.

Online supplemental material
----------------------------

This section presents additional experimental and modeling data. Fig. S1 displays representative traces of H~2~O~2~ emission obtained at different doses of AF or DNCB inhibition of the antioxidant defenses that are summarized in [Fig. 2](#fig2){ref-type="fig"}. Fig. S2 shows the steady-state behavior of the computational model as a function of the parameter representing the NADPH concentration. Online supplemental material is available at <http://www.jgp.org/cgi/content/full/jgp.201210772/DC1>.

![Effect of AF or DNCB on H~2~O~2~ emission from heart mitochondria under FET at states 4 and 3 of respiration. (A--C) Freshly isolated mitochondria (∼100 µg mitochondrial protein \[prot.\]) from mouse, rat, and guinea pig hearts were preincubated in the absence or the presence of the indicated concentrations of AF (left graphs) or DNCB (right graphs) in the presence of the NADH-linked substrates G/M (5 mM each). Monitoring of H~2~O~2~ was performed with the Amplex red assay during states 4 (with G/M) and 3 (+1 mM ADP) of mitochondrial respiration ([@bib63]). The specific fluxes of H~2~O~2~ emission are shown. The kinetic parameters describing the fluxes of H~2~O~2~ emission as a function of the inhibitor concentration, V~max~ and *K*~0.5~, were determined after nonlinear regression fitting of the experimental points with a hyperbolic Michaelis--Menten or Hill type of equation. The results ± SEM obtained from two experiments with duplicates in each are represented.](JGP_201210772_Fig2){#fig2}

RESULTS
=======

Kinetics of H~2~O~2~ emission flux from mitochondria upon inhibition of either the GSH or Trx system
----------------------------------------------------------------------------------------------------

We measured respiratory and H~2~O~2~ emission fluxes in parallel from mitochondria isolated from mouse, rat, and guinea pig hearts. As FET corresponds to the physiological mode of electron transport in the respiratory chain, we measured respiration in the presence of NADH-linked substrates (G/M, 5 mM each) without (state 4) or with (state 3) 1 mM ADP.

Two inhibitors, AF and DNCB, were used to selectively and equally inhibit, in the matrix and IMS, the Trx1/2 and GSH systems, respectively ([@bib63]). The main rationale underlying our approach was that the increase in ROS emission observed in respiring mitochondria in the presence of each individual inhibitor represents the amount of H~2~O~2~ being scavenged by that antioxidant system, assuming that the respiratory chain is the main supplier of ROS, Mn SOD is not rate controlling, and both GSH and Trx1/2 are the main scavenging systems in the mitochondrial matrix and IMS. Hence, the simultaneous blockade of both should render the maximum percentage of the total O~2~ consumption flux being diverted to ROS generation. Knowing the total increase in H~2~O~2~ emission obtained at maximal inhibition with both AF and DNCB, we can calculate (in percentage) the extent of scavenging performed by each system.

To choose the appropriate concentration of the inhibitor, we performed dose-response curves for AF and DNCB while monitoring H~2~O~2~ emission in mitochondria respiring under FET in states 4 and 3. The results are shown in [Fig. 2](#fig2){ref-type="fig"} for mouse ([Fig. 2 A](#fig2){ref-type="fig"}), rat ([Fig. 2 B](#fig2){ref-type="fig"}), and guinea pig ([Fig. 2 C](#fig2){ref-type="fig"}) mitochondria. Representative traces of the dynamics of H~2~O~2~ emission during state 4 and 3 respiration as a function of the inhibitor concentrations are shown in [Fig. S1](http://www.jgp.org/cgi/content/full/jgp.201210772/DC1){#supp1}. The maximal AF-elicited H~2~O~2~ fluxes obtained from mouse, rat, and guinea pig mitochondria under states 4/3 ([Fig. 2, A--C](#fig2){ref-type="fig"} \[left graphs\]) are summarized in [Table 3](#tbl3){ref-type="table"}. DNCB produced larger H~2~O~2~ fluxes from mouse and rat mitochondria in comparison with AF but similar ones in guinea pig ([Fig. 2, A--C](#fig2){ref-type="fig"} \[right graphs\]; [Table 3](#tbl3){ref-type="table"}). Also summarized in [Table 3](#tbl3){ref-type="table"} are the *K*~0.5~ inhibitory constants (dose of compound producing 50% of maximal H~2~O~2~ emission) by AF and DNCB in states 4/3 obtained from data in [Fig. 2](#fig2){ref-type="fig"}. Overall, the GSH-depleting agent increased H~2~O~2~ emission with a *K*~0.5~ approximately three orders of magnitude higher than the TrxR2 inhibitor for the mouse (0.95 µM vs. 1.32 nM) and two orders of magnitude for rat and guinea pig (1--2 µM vs. 3--15 nM). The H~2~O~2~ emission levels in the presence of each inhibitor differed according to species, likely reflecting a different participation of GSH and Trx systems in H~2~O~2~ scavenging.

###### 

Kinetics of H~2~O~2~ emission from mitochondria under FET in the absence or presence of inhibitors

  Condition                                                        Mouse         Rat         Guinea pig                              
  ---------------------------------------------------- ----------- ------------- ----------- ------------ ------------ ------------- ------------
  H~2~O~2~ emission[a](#tblfn2){ref-type="table-fn"}   Control     107 ± 1.5     82 ± 1.5    105 ± 2.5    80 ± 5       95 ± 3        62 ± 3
                                                       +AF         707 ± 65      585 ± 49    440 ± 29     271 ± 30     791 ± 92      678 ± 91
                                                       +DNCB       2085 ± 195    767 ± 165   2541 ± 210   1309 ± 144   512 ± 47      558 ± 31
  *K*~0.5~                                             AF (nM)     1.32 ± 0.5    0.4 ± 0.2   12.5 ± 3.7   15 ± 7       3.5 ± 1.5     4.1 ± 1.9
                                                       DNCB (µM)   0.95 ± 0.27   0.8 ± 0.5   2.1 ± 0.4    2.0 ± 0.76   1.05 ± 0.16   1.7 ± 0.12

H~2~O~2~ emission in all cases is expressed in pmol min^−1^ mg^−1^ protein.

H~2~O~2~ emission as a percentage of the total O~2~ consumption flux
--------------------------------------------------------------------

We then asked whether the continuous and concerted action of both scavenging systems was masking a higher flux of ROS production from the respiratory chain. To test this point, we applied both AF and DNCB together at concentrations (50 nM and 10 µM, respectively) that produce maximal H~2~O~2~ emission in all species analyzed. The total ROS flux as a percentage of the respiratory flux was determined from parallel measurements of O~2~ consumption and H~2~O~2~ emission in the same mitochondrial preparation from the three species.

The results obtained after maximal inhibition of the GSH and Trx1/2 systems are depicted in [Table 4](#tbl4){ref-type="table"}. The findings suggest that the low H~2~O~2~ emission observed under FET in both respiratory states 4 and 3 is a result of the continuous scavenging action by GSH and Trx1/2. For instance, the flux of H~2~O~2~ emission from rat mitochondria after complete inhibition of GSH and Trx1/2 systems under FET (in nmol H~2~O~2~ min^−1^ mg^−1^ protein) is 1.16 and 0.55, whereas the respiratory flux, VO~2~ (nmol min^−1^ mg^−1^ protein), under the same conditions is 35 and 202 in states 4 and 3, respectively. We calculated that the H~2~O~2~ emission represents 2 and 0.25% of the total O~2~ consumption flux in rat heart mitochondria under states 4 and 3, respectively. Data for mouse and guinea pig are also analyzed in [Table 4](#tbl4){ref-type="table"}, where it can be appreciated that mitochondria from both species represent two extreme situations. In mouse mitochondria, H~2~O~2~ emission represents 11 and 2.3% of the total O~2~ consumption in states 4 and 3, respectively, whereas in guinea pig, H~2~O~2~ rates amounted to only 0.7 and 0.3%.

###### 

Quantitation of respiration, H~2~O~2~ emission, and electron flow diversion to ROS in isolated heart mitochondria from three different species

               VO~2~           H~2~O~2~ emission[a](#tblfn3){ref-type="table-fn"}   Respiratory flux as H~2~O~2~ emission[b](#tblfn4){ref-type="table-fn"}                                                                           
  ------------ --------------- ---------------------------------------------------- ------------------------------------------------------------------------ --------------- ------------------------------------------------------- -------------------------------------------------------
               *nmol/min/mg*   *nmol/min/mg*                                        *nmol/min/mg*                                                            *nmol/min/mg*   *%*                                                     *%*
  Mouse        10 ± 2          47.5 ± 8                                             1.8 ± 0.03                                                               1.2 ± 0.08      11 (1 = 11 fold)[c](#tblfn5){ref-type="table-fn"}       2.3 (0.17 = 13 fold)[c](#tblfn5){ref-type="table-fn"}
  Rat          35 ± 5          202 ± 38                                             1.16 ± 0.03                                                              0.55 ± 0.04     2 (0.3 = ∼7 fold)[c](#tblfn5){ref-type="table-fn"}      0.25 (0.04 = 6 fold)[c](#tblfn5){ref-type="table-fn"}
  Guinea pig   46 ± 2.6        152 ± 8.5                                            0.56 ± 0.01                                                              0.48 ± 0.06     0.74 (0.2 = ∼4 fold)[c](#tblfn5){ref-type="table-fn"}   0.29 (0.04 = 7 fold)[c](#tblfn5){ref-type="table-fn"}

The H~2~O~2~ emission fluxes reported are those measured in the presence of both inhibitors simultaneously (50 nM AF + 10 µM DNCB).

The numbers shown correspond to the percentage of the O~2~ consumption flux diverted to ROS. These values are obtained from calculations using VO~2~ and H~2~O~2~ emission that are in the same units, with the values corrected for the increase in state 4 (60%; [Fig. 3 A](#fig3){ref-type="fig"}) and 3 (10%; [Fig. 3 B](#fig3){ref-type="fig"}) respiration produced by the presence of AF and DNCB together. For example, in the mouse in state 4 mitochondria, the H~2~O~2~ emission (=1.8) represents 11% of the O~2~ consumption flux (=10 + 6; this latter number is a result of the 60% increase in state 4 respiration, provoked by the presence of both inhibitors simultaneously, i.e., 10 × 0.6 = 6; see [Fig. 3 A](#fig3){ref-type="fig"}); thus, 1.8/16 × 100 = 11.2. A similar type of calculation was applied to all other cases.

These values represent the percentage of the respiratory flux diverted to ROS in states 4 and 3 under FET in the absence of inhibitors (see [Table 3](#tbl3){ref-type="table"}, Control row).

In all cases, state 4 displayed a higher percentage of ROS emission than state 3, with respect to respiration. However, it is worth noting that in state 3, the relative impact of mitochondrial antioxid ant system inhibition is greater than previously recognized in terms of controlling ROS emission ([Table 4](#tbl4){ref-type="table"}). To quantify this novel observation, we calculated the extent to which the H~2~O~2~ emission flux was originally underestimated under FET in the absence of inhibitors. For example, mouse mitochondria in state 4 emit 1% of VO~2~ as H~2~O~2~; however, in the presence of maximal inhibition, this increased 11 fold to 11%. Similarly, in all three species, the original values of H~2~O~2~ emitted per O~2~ consumed were underestimated between 4 and 11 fold under state 4 and from 6 to 13 fold under state 3 respiration ([Table 4](#tbl4){ref-type="table"}).

The doses of inhibitors used to obtain the data shown in [Table 4](#tbl4){ref-type="table"} were further tested to determine the effects exerted by AF and DNCB alone or together on VO~2~. In [Fig. 3](#fig3){ref-type="fig"}, we show the results obtained with mitochondria from guinea pig heart. The addition of either inhibitor alone had no effect on state 4 or state 3 respiration ([Fig. 3, A and B](#fig3){ref-type="fig"}). However, when added together, AF and DNCB significantly increased state 4 (∼60%) and only slightly increased (10%) state 3 respiration. These effects were taken into account in the values shown in [Table 4](#tbl4){ref-type="table"}.

![Respiration and redox behavior of mitochondria in the presence of AF and/or DNCB. (A and B) Freshly isolated mitochondria from guinea pig heart were handled and assayed, as described in Materials and methods. Mitochondrial respiration (VO~2~) was monitored under FET conditions in state 4 with G/M (A) and state 3 after addition of 1 mM ADP (B) in the absence or the presence of 50 nM AF or 10 µM DNCB or both together. The statistical significance of the differences between treatments was evaluated with ANOVA using Tukey's multiple comparison test (\*, p \< 0.05; \*\*\*, p \< 0.001). (C) The same mitochondrial preparation was analyzed in parallel by fluorometry for NADH and H~2~O~2~ emission (see [Table 4](#tbl4){ref-type="table"}), which were monitored simultaneously after preincubation, with the concentrations of AF and DNCB indicated. Arrows point to substrate (G/M and ADP) addition. In the whisker plots, the top and the bottom of the box represent the 75 and 25% percentile, respectively, whereas the line within the box is the median; the bars indicate the maximum and minimum values of the distribution. The numbers on top of the whisker plots correspond to the mean ± SEM (*n* = 12, with two experiments). prot., protein.](JGP_201210772_Fig3){#fig3}

Additionally, we tested the effects of the inhibitors given individually, or in combination, on NADH levels while simultaneously monitoring H~2~O~2~ emission. Other than increasing H~2~O~2~ flux from mitochondria ([Fig. 2](#fig2){ref-type="fig"}), AF and DNCB, individually or together, had no significant impact on the mitochondrial NADH response (normalized to the initial NADH fluorescence) upon substrate addition (G/M and ADP; [Fig. 3 C](#fig3){ref-type="fig"}). However, before substrate addition, the NADH pool was more oxidized (∼50%) in mitochondria preincubated with both inhibitors, consistent with the higher NADH oxidation rate indirectly indicated by the higher state 4 respiration ([Fig. 3 A](#fig3){ref-type="fig"}). Collectively the results depicted in [Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"} and additional data (not depicted) indicate that the behavior of the three species analyzed was similar.

Computational modeling of the Trx and GSH scavenging systems
------------------------------------------------------------

To better understand the dynamics of the concerted action of the GSH/Trx systems in mitochondria, we formulated a minimal model accounting for the known kinetics of the two systems. [Fig. 4 A](#fig4){ref-type="fig"} schematically depicts the processes taken into account (see Computational model formulation in Materials and methods). In this model scheme, the arrow pointing to H~2~O~2~ emission, V~H2O2~ emission, is in fact the resultant of the supply of H~2~O~2~ by V~SOD~ minus the consumption exerted by the two scavenging systems, which at the steady state can be written as follows:$$V_{H_{2}O_{2}\mathit{emission}} = {\text{V}_{\mathit{SOD}}\, - \,\text{V}_{\mathit{GPx}}\, - \, V_{\mathit{Prx}}.}$$The behavior of the model was studied as a function of the activity of V~SOD~ and for various combinations of the maximal rates of GSH and Trx subsystems varied through the catalytic rate constants of GR and TrxR.

![Time-dependent and steady-state behavior of the computational model of GSH/Trx systems. (A) The scheme of the computational model as described in Materials and methods. (B) The continuation analysis of the steady-state behavior as a function of the rate of H~2~O~2~ provision by SOD activity (V~SOD~); the latter was varied between 5 × 10^−5^ and 5.5 × 10^−4^ mM ms^−1^, with $k_{TrxR}^{1}$ = 0.022 ms^−1^ and $k_{GR}^{1}$ = 0.025 ms^−1^. (C) Time-dependent simulations showing the increase in the emission of H~2~O~2~ upon inhibition of $k_{TrxR}^{1}$ and $k_{GR}^{1}$, which were adjusted from 0.022 to 0.009 ms^−1^ and 0.025 to 0.005 ms^−1^, respectively, to represent the inhibitory action of AF and DNCB, respectively.](JGP_201210772_Fig4){#fig4}

A parametric condition representing a relative catalytic ratio of GR to TrxR of two was able to mimic the proportion contributed by each system to the scavenging observed experimentally. [Fig. 4 B](#fig4){ref-type="fig"} shows the plot of the rates of GPx, TrxR, and V~H2O2~ emission and the concentrations of Trx(SH)~2~ and GSH when the system is challenged with increasing H~2~O~2~ input (V~SOD~). The GSH system reached its maximal capacity at lower V~SOD~, as indicated by the consumption of GSH and the observed plateau of GPx activity. The TrxR system increased its rate upon saturation of the GSH system along with the rate of H~2~O~2~ emission. The maximal V~H2O2~ emission was attained after the H~2~O~2~ production exceeded the sum of the two scavenging systems, after which H~2~O~2~ emission increased almost proportionally with V~SOD~.

Model simulations show the time-dependent increase in V~H2O2~ when both scavenging systems are inhibited simultaneously ([Fig. 4 C](#fig4){ref-type="fig"}) or independently ([Fig. 5, A and B](#fig5){ref-type="fig"}). When simultaneously inhibited, loss of control over V~H2O2~ occurs only after both GSH and Trx(SH)~2~ are completely consumed, recapitulating the experimental observations under the same conditions ([Fig. 4 C](#fig4){ref-type="fig"}). In fact, the 17-fold increase obtained in the simulation is comparable with the values reported in [Table 4](#tbl4){ref-type="table"} for mouse mitochondria. As an example, in state 4 mouse mitochondria, the H~2~O~2~ emission in the absence of inhibitors represents 1% of VO~2~ (i.e., 10 × 0.01 = 0.1 nmol H~2~O~2~/min/mg protein; when the GSH and Trx systems are both inhibited, the H~2~O~2~ emission is 1.8 nmol H~2~O~2~/min/mg protein; thus, 1.8/0.1 = 18-fold increase in H~2~O~2~ emission). Lower values were detected in the case of guinea pig mitochondria ([Table 4](#tbl4){ref-type="table"}). Importantly, in mouse mitochondria, simulation of separate inhibition of TrxR2 ([Fig. 5 A](#fig5){ref-type="fig"}) or GR ([Fig. 5 B](#fig5){ref-type="fig"}) closely reproduces the shape and magnitude of the dose response of H~2~O~2~ emission to each one of the inhibitors ([Fig. 2 A](#fig2){ref-type="fig"}). A 4- and 19-fold increase in H~2~O~2~ emission could be simulated, close to the experimentally measured rise of ∼6 and 19 fold at state 4 with AF and DNCB, respectively ([Fig. 2 A](#fig2){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}).

![Model simulation of mitochondrial H~2~O~2~ emission after independent inhibition of Trx or GSH system. (A) To simulate AF inhibition with the computational model, the concentration of TrxR2 (Etrxm) was decreased from a control concentration of 0.002 to 10^−8^ mM. The steady-state values of H~2~O~2~ emission were estimated for each concentration at fixed GR (kcgrm = 0.0152). (B) DNCB inhibition was simulated by decreasing the concentration of GR (kcgrm) from a control value of 0.0215 mM to 10^−8^ mM and the steady-state values of H~2~O~2~ emission estimated at each concentration while keeping TrxR2 constant (Etrxm = 0.0035). In both cases, the percentage of inhibition was calculated by dividing the control concentration over the corresponding TrxR2 or GR concentration. The parameters used in this simulation were kcgpx = 0.013 mM, V~SOD~ = 8 × 10^−5^ mM ms^−1^, kpxx = 2.5 mM, and Prx3T = 0.5 mM.](JGP_201210772_Fig5){#fig5}

Model simulations also showed that H~2~O~2~ emission is highly dependent on NADPH levels (see [Fig. S2](http://www.jgp.org/cgi/content/full/jgp.201210772/DC1){#supp2}). When NADPH decreases below the *K*~m~ of GR and TrxR for NADPH (15 and 12 µM, respectively), the antioxidant capacity is quickly exhausted, and higher rates of H~2~O~2~ emission are observed (Fig. S2 and [Table 2](#tbl2){ref-type="table"}).

DISCUSSION
==========

In this work, we have addressed the following basic question: how much of the total flux of ROS produced by the respiratory chain is scavenged and, thus, is not accounted for in measurements of H~2~O~2~ emission from mitochondria? Here, we provide the following answers/observations: (a) the actual electron flux diverted to ROS production rather than O~2~ reduction by cytochrome oxidase can be much higher than previously estimated; and (b) the low H~2~O~2~ emission usually reported during FET is a result of the combined actions of the GSH and Trx1/2 systems, which continuously limit the amount of ROS escaping from mitochondria.

Our quantitative analysis indicates that if the scavenging contribution is not taken into account, the extent of ongoing ROS generation contributed by the respiratory chain is severely underestimated. This evidence is shown in [Table 4](#tbl4){ref-type="table"}. For the mouse mitochondria and rat and guinea pig mitochondria, the differences in the ROS rate amount to 11, 7, and 4 fold during state 4 respiration and 13, 6, and 7 fold in state 3 respiration, respectively ([Table 4](#tbl4){ref-type="table"}, last two columns).

Earlier measurements in state 4 during FET conducted in mitochondria from rat liver or pigeon heart estimated that the H~2~O~2~ emission represented ∼1--2% of the total O~2~ utilization ([@bib17]). Other authors reported lower values, namely in the range of 0.15--0.6% (see [Table 5](#tbl5){ref-type="table"}). Negligible H~2~O~2~ emission was purported to exist during state 3 respiration, although the levels were not actually determined. Our data indicate values in the range of 0.02--0.04% for mitochondria in state 3 from rat and guinea pig hearts; in the mouse, these values increased ∼10 times ([Table 5](#tbl5){ref-type="table"}). Our results point out that, without taking into account the ROS scavenging action, all previous values (including our own data; [@bib7]) represent underestimations of ROS production from the respiratory chain. The extent of underestimation can be as high as 11 fold in state 4 and 13 fold in state 3 mitochondria from mouse ([Table 4](#tbl4){ref-type="table"}). The standard explanation of the observed decrease in ROS emission during the state 4 to state 3 transition is that it results from ΔΨ~m~ depolarization ([@bib58]), which is a result of the activation of ATP synthesis and the concomitant consumption of ΔΨ~m~ by the ATP synthase, leading to an increase in proton pumping and respiration to reestablish the proton-motive force.

###### 

Literature survey of H~2~O~2~ emission and electron flow diversion to ROS under FET in isolated mitochondria from different organs and species

  Mitochondria source   Species      H~2~O~2~ emission       O~2~ consumption flux diverted to H~2~O~2~(State 4--State 3)   Reference    
  --------------------- ------------ ----------------------- -------------------------------------------------------------- ------------ ------------
                                     *nmol/min/mg protein*   *nmol/min/mg protein*                                          *%*          
  Heart                 Rat          0.02                    ND                                                             0.4--ND      [@bib30]
                                     ndet                    ND                                                                          [@bib66]
                                     0.105                   0.08                                                           0.3--0.04    This study
                        Pigeon       0.3--0.6                ND                                                             2--ND        [@bib17]
                                     ndet                    ND                                                                          [@bib66]
                        Guinea pig   0.075                   0.047                                                          0.6--0.016   [@bib7]
                                     0.095                   0.062                                                          0.2--0.04    This study
                        Mouse        0.107                   0.082                                                          1--0.17      This study
  Liver                 Rat          0.19                    0.08                                                           1-2--ND      [@bib13]
                                     0.25                    ND                                                             1.82--ND     [@bib31]
  Skeletal muscle       Rat          \<0.2                   ND                                                             ≤0.15--ND    [@bib66]

In all sources, FET is under G/M or Pyr/M (4--6 mM each). The only exception is [@bib66], in which the data reported in the table were obtained with palmitoyl carnitine. ndet, non-detected.

The present findings suggest that a large portion of the decrease in ROS emission in state 3 is a result of the action of the GSH and Trx systems, which offset a significant amount of O~2~^−^ production at complex I (e.g., flavin mononucleotide site) or complex III (e.g., ubisemiquinone). At the present stage, we cannot rule out that some unknown fraction of the scavenging systems is not inhibited by the compounds used in this work, which would result in even higher H~2~O~2~ production rates.

Recently, we showed that AF, an established antirheumatoid gold(I) drug that also exhibits anticancer activity ([@bib50]; [@bib53]), increased H~2~O~2~ emission from heart mitochondria by selectively inhibiting the TrxR/Trx/Prx system in the nanomolar range (\<10 nM; [@bib63]). Using a similar approach, a very recent study from [@bib40] shows the important contribution of the Trx2 system in H~2~O~2~ detoxification operated by mitochondria in rat hippocampus. Organic gold inhibitors such as AF ([@bib27]; [@bib69]) effectively target the selenocysteine of TrxR1 or TrxR2 because selenols bind more efficiently to heavy metals. We assumed that AF was inhibiting TrxR in both matrix and IMS compartments. In the same study, we showed that 2,4-DNCB, an alkylating and GSH-depleting agent ([@bib29]), increases H~2~O~2~ emission, likely through GSH-DNCB conjugation catalyzed by GSH *S*-transferase ([@bib45]). The inhibitory action of AF and DNCB appeared to be largely independent of one another, influencing H~2~O~2~ emission only, without substantially affecting mitochondrial energetics (ΔΨ~m~) and the redox status of NADH ([@bib63]). Notably, the participation of the Trx system is markedly higher than anticipated if one considers that the GSH concentration exceeds Trx by \>100 fold. In agreement with previously reported values ([@bib25]), our measurements in mouse mitochondria indicate that the GSH pool is 1--1.5 mM ([@bib63]), whereas Trx2 has been estimated to be 10 µM ([@bib20]). Speculatively, this could be explained by a closer localization of the Trx system, relative to GSH, to the sources of ROS in mitochondria.

Previous studies have shown a clear link between GSH depletion and H~2~O~2~ and O~2~^−^ generation in mitochondria and cells ([@bib29]; [@bib5], [@bib7]; [@bib63]). Apparently, in heart mitochondria, a certain degree of GSH depletion (∼30--40%) needs to be attained before a high H~2~O~2~ emission is manifested ([@bib29]). H~2~O~2~ emission under FET did not increase before overcoming a certain level of GSH depletion ([@bib29]; [@bib5]; [@bib63]). This behavior is reproduced by our minimal computational model in which the onset of the large increase of H~2~O~2~ emission occurs only when GSH and Trx(SH)~2~ levels decrease beyond a certain value ([Fig. 4](#fig4){ref-type="fig"}). Our model simulations show that the individual antioxidant systems can relieve each other when the catalytic capacity of either of them is overwhelmed. As a result, the overall function of the scavenging systems is highly dependent on NADPH that, as an electron donor, restores their scavenging ability (Fig. S2). The simulation results also suggest that GSH and Trx systems act interdependently; this interdependence can be not only kinetic but further could involve physical (molecular) interaction among components. In this latter case, inhibition of one system can negatively affect the proper function of the other. This may help to explain the higher fluxes of H~2~O~2~ emission registered when each system is inhibited independently rather than simultaneously (compare [Tables 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). This interesting aspect is under current investigation in our laboratory.

Several theoretical and pragmatic consequences arise from the findings reported in this work. First and foremost, the two main known antioxidant systems in the mitochondrial matrix work continuously and concertedly to offset ROS produced in the respiratory chain. Second, the H~2~O~2~ input from the respiratory chain to the scavenging systems is much greater than previously measured. These findings bring to the surface two additional relevant points: (1) the GSH/Trx systems exert a high degree of control over the H~2~O~2~ emission flux, which modulates the intramitochondrial and -cellular redox environment, and (2) in this context, the respiratory chain and the levels of O~2~ acquire a special importance because ROS production represents a relatively higher percentage of the total O~2~ consumption flux by mitochondria in comparison with previous estimations. Also, the participation of GSH and Trx systems in H~2~O~2~ scavenging may differ between different species as herein reported, and this divergence may become even more prominent with other animals of different size. This is an intriguing question to ponder in future studies. Finally, clinical trials testing the impact of antioxidants against acute and chronic cardiac conditions, such as ischemia/reperfusion injury and heart failure, have been rather disappointing, both in terms of functional outcome and prevention of mortality. One obvious explanation could be that some of these antioxidants do not really reach mitochondria, which are increasingly appreciated as a central source of ROS under stressful energetic and redox conditions. Another explanation could be that the maximum rates of reoxidation/recycling of the exogenously added antioxidants limit their effectiveness as compared with the native, finely tuned scavenger pathways. Our study provides a basic mechanistic platform upon which future studies aimed at preventing excessive ROS emission from mitochondria can be designed. In this sense, the strategies of reinforcing the mitochondrial matrix antioxidant defenses appear to be in the right direction ([@bib60]; [@bib42]; [@bib21]; [@bib62]). As has been previously discussed ([@bib36]), failure of antioxidant therapy might also be a consequence of disruption of redox-dependent signaling pathways that are vital for cells to display normal function ([@bib67]), for example the well-known effect of ROS to trigger increased expression of antioxidant enzymes via the Nrf2 antioxidant response element ([@bib44]).

Overall, the present findings reinforce the idea that mitochondria and their bacterial precursors, emerging at the dawn of aerobic life, have evolved powerful antioxidant systems whose coordinated actions continuously keep ROS levels within physiological limits to avoid oxidative damage while ensuring the preservation of vital signaling pathways and maximal energy output.
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